1 / 29

Europe Cervical Cancer Test Market

Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.

renubresearch
Download Presentation

Europe Cervical Cancer Test Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015. Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is119 Page market research report with115 Figures and 2 Tablespublished byRenub Research.

  2. Continue (www.renub.com) • All the 9 countries in the report have been studied from 3 viewpoints. • Cervical Cancer Test Market, Population & Mortality • Cervical Cancer Test Population (2008-2020) • Pap Smear Test Population & Forecast • HPV DNA Test Population & Forecast • Cervical Cancer Mortality Population (2001-2011) • Cervical Cancer Test Market (2008-2020) • Pap Smear Test Market & Forecast • HPV DNA Test Market & Forecast

  3. Continue (www.renub.com) • 9 Countries studied in the report are as follows • United Kingdom • France • Germany • Italy • Spain • Sweden • Switzerland • Norway • Netherlands

  4. Continue (www.renub.com) Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

  5. Continue (www.renub.com) Table of Contents 1. Executive Summary 2. Europe Cervical Cancer Test (Screening) Population & Forecast 3. Europe Cervical Cancer Test (Screening) Market & Forecast 3.1 Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast 3.2 Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast 4. Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast 4.1 Europe Cervical Cancer Test (Screening) Population Share & Forecast 4.2 Europe Cervical Cancer Test (Screening) Market Share & Forecast

  6. Continue (www.renub.com) 4.3 Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast 4.4 Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast 5. United Kingdom – Cervical Cancer Test Analysis 5.1 United Kingdom Cervical Cancer Test (Screening) Population 5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast 5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast 5.2 United Kingdom Cervical Cancer Deaths 5.3 United Kingdom Cervical Cancer Test (Screening) Analysis 5.3.1 United Kingdom Cervical Cancer Test Market & Forecast 5.3.2 United Kingdom Pap Smear Test Market & Forecast 5.3.3 United Kingdom HPV DNA Test Market & Forecast

  7. Continue (www.renub.com) 6. France – Cervical Cancer Test Analysis 6.1 France Cervical Cancer Test (Screening) Population 6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast 6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast 6.2 France Cervical Cancer Mortality 6.3 France Cervical Cancer Test (Screening) Analysis 6.3.1 France Cervical Cancer Test Market & Forecast 6.3.2 France Pap Smear Test Market & Forecast 6.3.3 France HPV DNA Test Market & Forecast 7. Germany – Cervical Cancer Test Analysis 7.1 Germany Cervical Cancer Test (Screening) Population 7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast 7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast 7.2 Germany Cervical Cancer Mortality

  8. Continue (www.renub.com) 7.3 Germany Cervical Cancer Test (Screening) Market 7.3.1 Germany Cervical Cancer Test Market & Forecast 7.3.2 Germany Pap Smear Test Market & Forecast 7.3.3 Germany HPV DNA Test Market & Forecast 8. Italy – Cervical Cancer Test Analysis 8.1 Italy Cervical Cancer Test (Screening) Population 8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast 8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast 8.2 Italy Cervical Cancer Mortality 8.3 Italy Cervical Cancer Test (Screening) Market 8.3.1 Italy Cervical Cancer Test Market & Forecast 8.3.2 Italy Pap Smear Test Market & Forecast 8.3.3 Italy HPV DNA Test Market & Forecast

  9. Continue (www.renub.com) 9. Spain – Cervical Cancer Test Analysis 9.1 Spain Cervical Cancer Test (Screening) Population 9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast 9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast 9.2 Spain Cervical Cancer Mortality 9.3 Spain Cervical Cancer Test (Screening) Market 9.3.1 Spain Cervical Cancer Test Market & Forecast 9.3.2 Spain Pap Smear Test Market & Forecast 9.3.3 Spain HPV DNA Test Market & Forecast 10. Sweden – Cervical Cancer Test Analysis 10.1 Sweden Cervical Cancer Test (Screening) Population 10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast 10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast 10.2 Sweden Cervical Cancer Mortality

  10. Continue (www.renub.com) 10.3 Sweden Cervical Cancer Test (Screening) Market 10.3.1 Sweden Cervical Cancer Test Market & Forecast 10.3.2 Sweden Pap Smear Test Market & Forecast 10.3.3 Sweden HPV DNA Test Market & Forecast 11. Switzerland – Cervical Cancer Test Analysis 11.1 Switzerland Cervical Cancer Test (Screening) Population 11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast 11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast 11.2 Switzerland Cervical Cancer Mortality 11.3 Switzerland Cervical Cancer Test (Screening) Market 11.3.1 Switzerland Cervical Cancer Test Market & Forecast 11.3.2 Switzerland Pap smear Test Market & Forecast 11.3.3 Switzerland HPV DNA Test Market & Forecast

  11. Continue (www.renub.com) 12. Norway – Cervical Cancer Test Analysis 12.1 Norway Cervical Cancer Test (Screening) Population 12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast 12.2 Norway Cervical Cancer Mortality 12.3 Norway Cervical Cancer Test (Screening) Market 12.3.1 Norway Cervical Cancer Test Market & Forecast 12.3.2 Norway Pap Smear Test Market & Forecast 12.3.3 Norway HPV DNA Test Market & Forecast 13. Netherlands – Cervical Cancer Test Analysis 13.1 Netherlands Cervical Cancer Test (Screening) Population 13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast 13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast

  12. Continue (www.renub.com) 13.2 Netherlands Cervical Cancer Mortality 13.3 Netherlands Cervical Cancer Test (Screening) Market 13.3.1 Netherlands Cervical Cancer Test Market & Forecast 13.3.2 Netherlands Pap Smear Test Market & Forecast 13.3.3 Netherlands HPV DNA Test Market & Forecast 14. Cervical Cancer Test Market Growth Drivers 14.1 Rising Cases of Teenage Sexual Cases Globally 14.2 Huge Prevalence of HPV Infected Patients Globally 15. Challenges in Cervical Cancer Test Market 15.1 Introduction of HPV Vaccination Programs Globally

  13. Continue (www.renub.com) List of Figures Figure 2 1: Europe – Cervical Cancer Test Population (Million), 2008 – 2015 Figure 2 2: Europe – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020 Figure 3 1: Europe – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 3 2: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 3 3: Europe – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015 Figure 3 4: Europe – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020 Figure 3 5: Europe – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015 Figure 3 6: Europe – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020

  14. Continue (www.renub.com) Figure 4 1: Europe – Cervical Cancer Test Population Share (Percent), 2008 – 2015 Figure 4 2: Europe – Forecast for Cervical Cancer Test Population Share (Percent), 2016 – 2020 Figure 4 3: Europe – Cervical Cancer Test Market Share (Percent), 2008 – 2015 Figure 4 4: Europe – Forecast for Cervical Cancer Test Market Share (Percent), 2016 – 2020 Figure 4 5: Europe – Cervical Cancer Pap Smear Test Market Share (Percent), 2008 – 2015 Figure 4 6: Europe – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 – 2020 Figure 4 7: Europe – Cervical Cancer HPV DNA Test Market Share (Percent), 2008 – 2015 Figure 4 8: Europe – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 – 2020

  15. Continue (www.renub.com) Figure 5 1: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 5 2: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 5 3: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 5 4: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 5 5: United Kingdom – Cervical Cancer Deaths (Number), 2001 – 2011 Figure 5 6: United Kingdom – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 5 7: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 5 8: United Kingdom – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 5 9: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 5 10: United Kingdom – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 5 11: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  16. Continue (www.renub.com) Figure 6 1: France – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 6 2: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 6 3: France – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 6 4: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 6 5: France – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 6 6: France – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 6 7: France – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 6 8: France – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 6 9: France – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 6 10: France – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 6 11: France – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  17. Continue (www.renub.com) Figure 7 1: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 7 2: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 7 3: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2005 – 2013 Figure 7 4: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2020 Figure 7 5: Germany – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 7 6: Germany – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 7 7: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 7 8: Germany – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 7 9: Germany – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 7 10: Germany – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 7 11: Germany – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  18. Continue (www.renub.com) Figure 8 1: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 8 2: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 8 3: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 8 4: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 8 5: Italy – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 8 6: Italy – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 8 7: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 8 8: Italy – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 8 9: Italy – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 8 10: Italy – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 8 11: Italy – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  19. Continue (www.renub.com) Figure 9 1: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 9 2: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 9 3: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 9 4: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 –2020 Figure 9 5: Spain – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 9 6: Spain – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 9 7: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 9 8: Spain – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 9 9: Spain – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 9 10: Spain – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 9 11: Spain – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  20. Continue (www.renub.com) Figure 10 1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 10 2: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 10 3: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 10 4: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 10 5: Sweden – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 10 6: Sweden – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 10 7: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 10 8: Sweden – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 10 9: Sweden – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 10 10: Sweden – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 10 11: Sweden – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  21. Continue (www.renub.com) Figure 11 1: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 11 2: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 11 3: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 11 4: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 11 5: Switzerland – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 11 6: Switzerland – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 11 7: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 11 8: Switzerland – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 11 9: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 11 10: Switzerland – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 11 11: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  22. Continue (www.renub.com) Figure 12 1: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 12 2: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 12 3: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 12 4: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 12 5: Norway – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 12 6: Norway – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 12 7: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 12 8: Norway – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 12 9: Norway – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 12 10: Norway – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 12 11: Norway – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  23. Continue (www.renub.com) Figure 13 1: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015 Figure 13 2: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020 Figure 13 3: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015 Figure 13 4: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020 Figure 13 5: Netherlands – Cervical Cancer Mortality (Number), 2001 – 2011 Figure 13 6: Netherlands – Cervical Cancer Test Market (Million US$), 2008 – 2015 Figure 13 7: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020 Figure 13 8: Netherlands – Pap Smear Test Market (Million US$), 2008 – 2015 Figure 13 9: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020 Figure 13 10: Netherlands – HPV DNA Test Market (Million US$), 2008 – 2015 Figure 13 11: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

  24. Continue (www.renub.com) List of Tables Table 25 3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006 Table 25 4: Worldwide – HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010

  25. Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Questions? Please call +1-678-302-0700 (USA) +91-120-421-9822 (India), +91-120-424-9780 or mail to info@renub.com

  26. Format Report Title: Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/europe-cervical-cancer-test-market-patients-by-screening-type-pap-smear-hpv-dna-united-kingdom-france-germany-italy-spain-sweden-switzerland-norway-netherlands-989-p.php

  27. Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

  28. Contact Information for Order by Check First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:

More Related